Article
Untargeted metabolomics to understand the basis of phenotypic differences in amphotericin B-resistant Leishmania parasites
2019-11-13
Abstract excerpt
<h4>Background: </h4> : Protozoan Leishmania parasites are responsible for a range of clinical infections that represent a substantial challenge for global health. Amphotericin B (AmB) is increasingly used to treat Leishmania infection, so understanding the potential for resistance to this drug is an important priority. Previously we described four independently-derived AmB-resistant L. mexicana lines that exhi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e8b97bb0-250d-5d65-a0ab-8555eb40b166
- DOI
- 10.12688/wellcomeopenres.15452.1
